Emotional and physical experiences of people with neovascular age-related macular degeneration during the injection process in Germany: a qualitative study
Objectives In order to better understand the continued barriers to the provision of vascular endothelial inhibitor therapy, this study aims to investigate patients’ experiences with neovascular age-related macular degeneration (nvAMD) in Germany during the injection process and how they deal with it...
Saved in:
Main Authors: | Oliver Zeitz, Martina Breuning, Christine Holmberg, Christian Wolfram, Anne Thier |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/6/e058266.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The first experience with brolucizumab for neovascular age-related macular degeneration
by: A.N. Kulikov, et al.
Published: (2022-05-01) -
Dry and neovascular “wet” age-related macular degeneration: Upcoming therapies
by: Audrey Yan, et al.
Published: (2025-01-01) -
Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany
by: Joachim Wachtlin, et al.
Published: (2020-01-01) -
Treatment for neovascular age-related macular degeneration: reasonable expectations of physicians and patients
by: A.B. Durasov
Published: (2021-09-01) -
Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration
by: Ilias Zampros, et al.
Published: (2012-01-01)